FDA Inspection 1149124 — Thomas G. Martin III, MD

Thomas G. Martin III, MD — FEI 3019511180

The FDA completed an inspection of Thomas G. Martin III, MD on July 29, 2021 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 29, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
San Francisco, CA (United States)